PEP heads into its July 9 Q2 earnings print carrying a notable divergence: short interest has jumped sharply over the past month, yet options traders have swung to their most bullish positioning of the past year.
The short-interest story is the more striking development. Bearish positioning has climbed roughly 25% over the past month, with short interest now running at 2.2% of the free float — still a modest absolute level for a mega-cap staples name, but the direction of travel is hard to ignore. The move happened in a single step: shorts added aggressively in the week ended June 24, taking the position from around 25 million shares to just under 31 million. That step-change arrived right as the stock was sliding, with PEP down 6% over the past month to $135.40, including a 4.7% drop on the week. Despite the growing short book, the borrow market remains entirely untroubled. Availability is close to limitless — over 939 million shares are available to lend — and cost to borrow is essentially flat at 0.39%, near its lowest level of the past six weeks. Short sellers face no squeeze pressure whatsoever.
Options positioning tells a sharply different story. The put/call ratio has dropped to 0.42 — the lowest reading of the past 52 weeks, against a 20-day average of 0.54 and nearly three standard deviations below it. That is the most call-heavy positioning PEP options have seen all year, suggesting some investors are positioning for a bounce or buying upside protection ahead of the print rather than hedging downside. The contrast with the rising short book is the defining tension of this setup: shorts are building, but options traders are leaning the other way.
The Street has spent the past few weeks marking down its expectations, though the tone remains broadly constructive. JP Morgan cut its price target to $170 from $178 this week while keeping an Overweight rating. Citigroup and BofA Securities both trimmed targets last week — Citi to $170 from $182, BofA to $164 from $173 — and Deutsche Bank lowered to $168 the week before. Every recent move has been a target cut rather than a downgrade, pointing to a Street that still sees meaningful upside from $135 but is recalibrating on near-term headwinds. The consensus mean target sits near $167, implying roughly 23% upside — a spread that reflects genuine uncertainty rather than conviction in either direction. Bernstein initiated fresh coverage at Market Perform with a $143 target, the most cautious recent voice. Valuation multiples have drifted lower: the forward P/E has contracted almost a full turn over the past month to around 16x, and price-to-book has slipped half a turn to 7.7x, compressing as the stock has fallen. One factor score stands out: PEP's dividend rank is in the 98th percentile, a reminder that income-focused holders have a structural reason to stay.
The bull case rests on brand durability, international expansion, and a new earnings print that a recent note credited with stronger-than-expected Q2 organic growth and raised full-year guidance. Bears point to North American snack volumes, commodity cost pressure, and a consumer still cautious about discretionary spending within the staples aisle. The most recent earnings history is mixed: the stock gained less than 1% on the day after the May 2026 print, then fell 3.7% over the following week; the April print saw a more benign 5-day reaction. Neither suggests a reliably large move in either direction.
Closest peer KO gained 1.2% on the week while PEP fell 4.7% — a meaningful divergence within the same consumer staples segment that reinforces the company-specific nature of the current pressure. The July 9 print is therefore the key event: whether the Q2 numbers and guidance can close the gap between a stock near multi-year lows and a Street that still has targets clustered in the $160s is the question that short sellers and options bulls are currently betting on from opposite sides.
See the live data behind this article on ORTEX.
Open PEP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
